ask="5.19"
ask_size="100"
average_daily_volume="339931"
bid="3.82"
bid_size="400"
book_value="3.74"
change="-0.31"
change_from_200_day_moving_average="1.19"
change_from_50_day_moving_average="-0.36"
change_from_52_week_high="-7.10"
change_From_52_week_low="0.39"
change_in_percent="-7.40%"
close="3.88"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="13899000"
high="4.23"
high_52_weeks="10.98"
last_trade_date="2/23/2017"
last_trade_price="3.88"
last_trade_size="1866"
last_trade_time="4:00pm"
low="3.86"
low_52_weeks="3.49"
market_capitalization="87.50M"
moving_average_200_day="2.69"
moving_average_50_day="4.24"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.23"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+44.49%"
percent_change_from_50_day_moving_average="-8.44%"
percent_change_from_52_week_high="-64.66%"
percent_change_from_52_week_low="+11.17%"
previous_close="4.19"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.12"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="2.62"
stock_exchange="NMS"
symbol="CASC"
volume="251498"
weeks_range_52="3.49 - 10.98"
